1. Home
  2. TVTX vs ALRM Comparison

TVTX vs ALRM Comparison

Compare TVTX & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • ALRM
  • Stock Information
  • Founded
  • TVTX 2008
  • ALRM 2000
  • Country
  • TVTX United States
  • ALRM United States
  • Employees
  • TVTX N/A
  • ALRM N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • ALRM Computer Software: Prepackaged Software
  • Sector
  • TVTX Health Care
  • ALRM Technology
  • Exchange
  • TVTX Nasdaq
  • ALRM Nasdaq
  • Market Cap
  • TVTX 3.1B
  • ALRM 2.8B
  • IPO Year
  • TVTX N/A
  • ALRM 2015
  • Fundamental
  • Price
  • TVTX $35.18
  • ALRM $48.15
  • Analyst Decision
  • TVTX Strong Buy
  • ALRM Buy
  • Analyst Count
  • TVTX 15
  • ALRM 3
  • Target Price
  • TVTX $37.21
  • ALRM $64.67
  • AVG Volume (30 Days)
  • TVTX 2.1M
  • ALRM 355.0K
  • Earning Date
  • TVTX 10-30-2025
  • ALRM 11-06-2025
  • Dividend Yield
  • TVTX N/A
  • ALRM N/A
  • EPS Growth
  • TVTX N/A
  • ALRM 1.77
  • EPS
  • TVTX N/A
  • ALRM 2.36
  • Revenue
  • TVTX $435,826,000.00
  • ALRM $991,770,000.00
  • Revenue This Year
  • TVTX $108.68
  • ALRM $7.89
  • Revenue Next Year
  • TVTX $40.23
  • ALRM $4.24
  • P/E Ratio
  • TVTX N/A
  • ALRM $21.35
  • Revenue Growth
  • TVTX 114.22
  • ALRM 7.36
  • 52 Week Low
  • TVTX $12.91
  • ALRM $46.65
  • 52 Week High
  • TVTX $36.76
  • ALRM $70.06
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 66.12
  • ALRM 39.30
  • Support Level
  • TVTX $33.05
  • ALRM $49.23
  • Resistance Level
  • TVTX $36.76
  • ALRM $51.26
  • Average True Range (ATR)
  • TVTX 1.95
  • ALRM 1.42
  • MACD
  • TVTX -0.02
  • ALRM 0.15
  • Stochastic Oscillator
  • TVTX 80.99
  • ALRM 28.52

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About ALRM Alarm.com Holdings Inc.

Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.

Share on Social Networks: